NECTAR LIFESCIENCES
Back to Balance Sheet
|
NECTAR LIFESCIENCES Last 5 Year Contingent Liabilities History
[Consolidated]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Contingent Liabilities | ₹230 Cr | ₹102 Cr | ₹198 Cr | ₹161 Cr | ₹76 Cr |
What is the latest Contingent Liabilities ratio of NECTAR LIFESCIENCES ?
| Year | Contingent Liabilities |
|---|---|
| Mar2026 | ₹230 Cr |
| Mar2025 | ₹102 Cr |
| Mar2024 | ₹198 Cr |
| Mar2023 | ₹161 Cr |
| Mar2022 | ₹76 Cr |
How is Contingent Liabilities of NECTAR LIFESCIENCES Trending?
| Years | Contingent Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹230 Cr | 125.14 | |
| Mar2025 | ₹102 Cr | -48.56 | |
| Mar2024 | ₹198 Cr | 22.75 | |
| Mar2023 | ₹161 Cr | 113.41 | |
| Mar2022 | ₹76 Cr | - | |
Compare Contingent Liabilities of peers of NECTAR LIFESCIENCES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NECTAR LIFESCIENCES | ₹254.7 Cr | 23.3% | 28.5% | -18% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹455,994.0 Cr | -0% | -4.5% | 15.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹240,249.0 Cr | 5.9% | 16.1% | 49.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹191,135.0 Cr | 3% | 3% | 34% | Stock Analytics | |
| CIPLA | ₹114,708.0 Cr | -0.4% | -3.6% | -11.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹98,074.9 Cr | NA | 2.8% | -7.1% | Stock Analytics | |
NECTAR LIFESCIENCES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NECTAR LIFESCIENCES | 23.3% |
28.5% |
-18% |
| SENSEX | -0.8% |
0.2% |
-6% |
You may also like the below Video Courses